Targeted neoadjuvant therapy in the HER-2-positive breast cancer patients: a systematic review and meta-analysis

Wenhua Ma1, Fugang Zhao2, Changpeng Zhou1

  • 1Department of Oncology, The First Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei Province, China.

Oncotargets and Therapy
|January 19, 2019
PubMed
Abstract

Insights

Lapatinib showed less efficacy and more adverse effects than trastuzumab in HER-2 positive breast cancer. Combining both drugs with chemotherapy improved pathological complete response but did not significantly enhance survival rates.

Area of Science:

  • Oncology
  • Pharmacology
  • Clinical Trials

Background:

  • HER-2 positive breast cancer requires targeted therapies.
  • Lapatinib and trastuzumab are HER-2 targeted agents.
  • Chemotherapy is a standard treatment for breast cancer.

Purpose of the Study:

  • To compare the efficacy and safety of lapatinib versus trastuzumab, both alone and in combination with chemotherapy.
  • To evaluate these treatments in HER-2 positive breast cancer patients undergoing neoadjuvant therapy.

Main Methods:

  • A systematic literature search was conducted across multiple databases.
  • Keywords included "breast cancer", "preoperative", "neo-adjuvant", "lapatinib", and "trastuzumab".
  • Meta-analysis was used to synthesize data from controlled trials up to December 2017.

Main Results:

  • Chemotherapy plus lapatinib was less effective and safe than chemotherapy plus trastuzumab regarding pathological complete response (PCR) and tall PCR (tPCR).
  • Combining chemotherapy with both lapatinib and trastuzumab significantly improved PCR and tPCR compared to trastuzumab alone.
  • Increased incidence of diarrhea, hepatic toxicity, and skin rash was observed with lapatinib-containing regimens.

Conclusions:

  • Lapatinib demonstrated lower efficacy and higher adverse event rates than trastuzumab.
  • The combination of chemotherapy with both lapatinib and trastuzumab enhanced PCR and tPCR but did not significantly improve survival outcomes.
  • Lapatinib-containing regimens were associated with increased gastrointestinal and dermatological toxicities.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H01:13

meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H

All meta-directing substituents are deactivating groups. These substituents withdraw electrons from the aromatic ring, making the ring less reactive toward electrophilic substitution. For example, the nitration of nitrobenzene is 100,000 times slower than that of benzene because of the deactivating effect of the nitro group. The first step in an electrophilic aromatic substitution is the addition of an electrophile to form a resonance-stabilized carbocation. The energy diagrams for...
6.7K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Review and Preview01:10

Review and Preview

In statistics, several tools are used to interpret the data. Measures of central tendency represent the characteristics of the data, such as mean, median, and mode. Additionally, measures of variance like standard deviation and range are used to find the spread of data from the mean. Relative standing measures the distance between data locations. Commonly used measures of relative standings are percentile, z score, and quartiles.
Percentiles are a type of fractile that partition data into...
8.4K
Review and Preview01:13

Review and Preview

Data are individual items of information obtained from a population or sample. Data may be classified as qualitative (categorical), quantitative continuous, or quantitative discrete. Because it is not practical to measure the entire population in a study, researchers use samples to represent the population. A random sample is a representative group from the population chosen by using a method that gives each individual in the population an equal chance of being included in the sample. Random...
11.2K
Random and Systematic Errors01:20

Random and Systematic Errors

Scientists always try their best to record measurements with the utmost accuracy and precision. However, sometimes errors do occur. These errors can be random or systematic. Random errors are observed due to the inconsistency or fluctuation in the measurement process, or variations in the quantity itself that is being measured. Such errors fluctuate from being greater than or less than the true value in repeated measurements. Consider a scientist measuring the length of an earthworm using a...
14.9K